Search Results - "Derova, J."

Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence by Kruis, W., Kardalinos, V., Eisenbach, T., Lukas, M., Vich, T., Bunganic, I., Pokrotnieks, J., Derova, J., Kondrackiene, J., Safadi, R., Tuculanu, D., Tulassay, Z., Banai, J., Curtin, A., Dorofeyev, A. E., Zakko, S. F., Ferreira, N., Björck, S., Diez Alonso, M. M., Mäkelä, J., Talley, N. J., Dilger, K., Greinwald, R., Mohrbacher, R., Spiller, R.

“…Summary Background Previous studies have reached conflicting conclusions regarding the efficacy of mesalazine in the prevention of recurrent diverticulitis…”
Get full text

THE SMALL BOWEL VIDEO CAPSULE ENDOSCOPY - TEN YEARS EXPERIENCE IN LATVIA by Rodina, J, Derovs, A, Derova, J, Pokrotnieks, J

“…Video capsule endoscopy (VCE) is relatively new, informative and minimally invasive endoscopic diagnostic method for assessment of the small bowel mucosa. To…”
Get more information

Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial by Dignass, Axel, Stoynov, Simeon, Dorofeyev, Andrey E., Grigorieva, Galina A., Tomsová, Eva, Altorjay, István, Tuculanu, Daniel, Bunganič, Ivan, Pokrotnieks, Juris, Kupčinskas, Limas, Dilger, Karin, Greinwald, Roland, Mueller, Ralph

“…Oral budesonide 9mg/day represents first-line treatment of mild-to-moderately active ileocolonic Crohn's disease. However, there is no precise recommendation…”
Get full text

P606 Once-daily versus three-times-daily oral budesonide in active Crohn's disease: a double-blind, double-dummy, randomized trial by Dignass, A., Grinevich, V., Zakharash, M., Goldis, A., Jonaitis, L., Gabalec, L., Vasileva, G., Rácz, I., Pekárková, B., Derova, J., Greinwald, R., Mueller, R.

Get full text

P048 SMALL BOWEL CAPSULE ENDOSCOPY IN PEDIATRIC PATIENTS: FIRST TEN PATIENTS by Derovs, A., Eglite, I., Derova, J., Pokrotnieks, J.

Get full text